Hisao Asamura

Hisao Asamura's AcademicInfluence.com Rankings

Hisao Asamura

Medical

#2671

World Rank

#3102

Historical Rank

Oncology

#171

World Rank

#177

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Hisao Asamura Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Hisao Asamura's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma (2011) (3193)
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer (2016) (2632)
The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer (2009) (938)
Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy (2008) (674)
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer (2015) (480)
A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). (2010) (479)
The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part‐Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer (2016) (443)
A Prospective Radiological Study of Thin-Section Computed Tomography to Predict Pathological Noninvasiveness in Peripheral Clinical IA Lung Cancer (Japan Clinical Oncology Group 0201) (2011) (421)
Neuroendocrine neoplasms of the lung: a prognostic spectrum. (2006) (419)
A review of 79 thymomas: Modification of staging system and reappraisal of conventional division into invasive and non‐invasive thymoma (1994) (398)
A Japanese Lung Cancer Registry Study: Prognosis of 13,010 Resected Lung Cancers (2008) (396)
TNM Atlas : Illustrated Guide to the TNM Classification of Malignant Tumours (2005) (328)
The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposal for an Evidence-Based Stage Classification System for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors (2014) (300)
Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database (2012) (296)
STAT6 Immunohistochemistry Is Helpful in the Diagnosis of Solitary Fibrous Tumors (2014) (287)
"Early" peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan. (2002) (286)
Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases. (2002) (283)
The IASLC Lung Cancer Staging Project: The New Database to Inform the Eighth Edition of the TNM Classification of Lung Cancer (2014) (273)
Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study. (2005) (272)
Comprehensive Histologic Analysis of ALK-Rearranged Lung Carcinomas (2011) (269)
Radiologic classification of small adenocarcinoma of the lung: radiologic-pathologic correlation and its prognostic impact. (2006) (266)
Japanese Lung Cancer Registry Study of 11,663 Surgical Cases in 2004: Demographic and Prognosis Changes Over Decade (2011) (266)
Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. (2001) (263)
The IASLC Lung Cancer Staging Project: Proposals for the Inclusion of Broncho-Pulmonary Carcinoid Tumors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer (2008) (262)
Lung cancer — major changes in the American Joint Committee on Cancer eighth edition cancer staging manual (2017) (257)
Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for video-assisted lobectomy? (1996) (257)
Bronchopleural fistulas associated with lung cancer operations. Univariate and multivariate analysis of risk factors, management, and outcome. (1992) (253)
Pulmonary resection for metastatic colorectal cancer: experiences with 159 patients. (1996) (247)
Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial. (2019) (241)
Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis. (1999) (239)
Radiographically determined noninvasive adenocarcinoma of the lung: survival outcomes of Japan Clinical Oncology Group 0201. (2013) (233)
Recommendations for Uniform Definitions of Surgical Techniques for Malignant Pleural Mesothelioma: A Consensus Report of the International Association for the Study of Lung Cancer International Staging Committee and the International Mesothelioma Interest Group (2011) (224)
The Clinical Relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 Network in Chemoresistant Non-small-cell Lung Cancer (2015) (213)
The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations. (2013) (210)
Scientific Advances in Lung Cancer 2015 (2016) (207)
Thymoma: a clinicopathologic study based on the new World Health Organization classification. (2003) (204)
The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer (2017) (203)
The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer (2016) (197)
Lymph node sampling in lung cancer: how should it be done? (1999) (193)
Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift. (2010) (183)
Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group trial 9806. (2008) (174)
A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions. (2003) (166)
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial (2022) (164)
Lung Adenocarcinoma With Mixed Bronchioloalveolar and Invasive Components: Clinicopathological Features, Subclassification by Extent of Invasive Foci, and Immunohistochemical Characterization (2003) (161)
Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification (2011) (159)
Extended resection of the left atrium, great vessels, or both for lung cancer. (1994) (158)
Recent results of postoperative mortality for surgical resections in lung cancer. (2004) (152)
The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification (2016) (152)
ROS1-Rearranged Lung Cancer: A Clinicopathologic and Molecular Study of 15 Surgical Cases (2013) (150)
Grade of Stromal Invasion in Small Adenocarcinoma of the Lung: Histopathological Minimal Invasion and Prognosis (2004) (149)
Pulmonary Resection in Patients Aged 80 Years or Over with Clinical Stage I Non-small Cell Lung Cancer: Prognostic Factors for Overall Survival and Risk Factors for Postoperative Complications (2009) (145)
c-MET/Phospho-MET Protein Expression and MET Gene Copy Number in Non-small Cell Lung Carcinomas (2012) (133)
Immunohistochemical KIT (CD117) expression in thymic epithelial tumors. (2005) (130)
Immunohistochemical detection of ROS1 is useful for identifying ROS1 rearrangements in lung cancers (2014) (129)
RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis (2014) (128)
The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the T Component for the forthcoming (8th) edition of the TNM classification of malignant tumors. (2014) (127)
Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma (2007) (125)
Clinicopathological features of nonsmall cell lung carcinomas with BRAF mutations. (2014) (119)
Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy. (2005) (118)
Reliability of Small Biopsy Samples Compared With Resected Specimens for the Determination of Programmed Death-Ligand 1 Expression in Non--Small-Cell Lung Cancer. (2015) (117)
Implications of staging in lung cancer. (1997) (116)
Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage Classification? (2011) (116)
Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung. (2005) (116)
Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer. (2016) (112)
Prognostic significance of pleural lavage cytology immediately after thoracotomy in patients with lung cancer. (1993) (106)
The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification (2009) (104)
What are the risk factors for arrhythmias after thoracic operations? A retrospective multivariate analysis of 267 consecutive thoracic operations. (1993) (104)
Japanese Lung Cancer Registry Study: First Prospective Enrollment of a Large Number of Surgical and Nonsurgical Cases in 2002 (2010) (103)
The ITMIG/IASLC Thymic Epithelial Tumors Staging Project: A Proposed Lymph Node Map for Thymic Epithelial Tumors in the Forthcoming 8th Edition of the TNM Classification of Malignant Tumors (2014) (100)
hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors (2004) (97)
Survival Differences by Gender for Resected Non-small Cell Lung Cancer: A Retrospective Analysis of 12,509 Cases in a Japanese Lung Cancer Registry Study (2010) (96)
Ultra-High-Resolution Computed Tomography of the Lung: Image Quality of a Prototype Scanner (2015) (93)
Long-term outcome and prognostic factors of surgically treated thymic carcinoma: results of 306 cases from a Japanese Nationwide Database Study. (2016) (92)
Visceral Pleura Invasion Impact on Non-small Cell Lung Cancer Patient Survival: Its Implications for the Forthcoming TNM Staging Based on a Large-Scale Nation-Wide Database (2009) (92)
Utility of 10 Immunohistochemical Markers Including Novel Markers (Desmocollin-3, Glypican 3, S100A2, S100A7, and Sox-2) for Differential Diagnosis of Squamous Cell Carcinoma from Adenocarcinoma of the Lung (2011) (90)
Prognostic Impact of Margin Distance and Tumor Spread Through Air Spaces in Limited Resection for Primary Lung Cancer (2017) (89)
CT findings of surgically resected large cell neuroendocrine carcinoma of the lung in 38 patients. (2004) (89)
Demographics, Safety and Quality, and Prognostic Information in Both the Seventh and Eighth Editions of the TNM Classification in 18,973 Surgical Cases of the Japanese Joint Committee of Lung Cancer Registry Database in 2010 (2019) (89)
Where is the boundary between N1 and N2 stations in lung cancer? (2000) (85)
Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinoma (2006) (85)
Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007 (2008) (84)
Prospective Study of the Accuracy of EGFR Mutational Analysis by High-Resolution Melting Analysis in Small Samples Obtained from Patients with Non–Small Cell Lung Cancer (2008) (83)
Hippo Pathway Gene Mutations in Malignant Mesothelioma: Revealed by RNA and Targeted Exon Sequencing (2015) (82)
Solitary Pure Ground-Glass Nodules 5 mm or Smaller: Frequency of Growth. (2015) (81)
The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer (2016) (81)
Promoter Methylation of DAL-1/4.1B Predicts Poor Prognosis in Non–Small Cell Lung Cancer (2005) (78)
Fluoroscopy-assisted thoracoscopic surgery after computed tomography-guided bronchoscopic barium marking. (2001) (77)
Epidermal growth factor receptor mutation status and clinicopathological features of combined small cell carcinoma with adenocarcinoma of the lung (2007) (76)
Combined resection of superior vena cava for lung carcinoma: prognostic significance of patterns of superior vena cava invasion. (2004) (73)
The IASLC/ITMIG Thymic Malignancies Staging Project: Development of a Stage Classification for Thymic Malignancies (2013) (72)
A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer. (2020) (72)
Histological Scoring for Small Lung Adenocarcinomas 2 cm or Less in Diameter: A Reliable Prognostic Indicator (2010) (72)
Inflammatory myofibroblastic tumor of the lung. (2004) (70)
Clinicopathologic features of peripheral squamous cell carcinoma of the lung. (2004) (68)
Lobe‐Specific Nodal Dissection for Clinical Stage I and II NSCLC: Japanese Multi‐Institutional Retrospective Study Using a Propensity Score Analysis (2016) (68)
Surgery for Small Cell Lung Cancer: A Retrospective Analysis of 243 Patients from Japanese Lung Cancer Registry in 2004 (2014) (68)
Clinical features and management of bronchogenic cysts: Report of 17 cases (2006) (68)
Ciliated Muconodular Papillary Tumors of the Lung: A Clinicopathologic Analysis of 10 Cases (2015) (67)
The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposals for the N and M Components for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors (2014) (67)
Limited resection for early-stage non-small cell lung cancer as function-preserving radical surgery: a review. (2017) (65)
Visceral Pleural Invasion Classification in Non–Small-Cell Lung Cancer in the 7th Edition of the Tumor, Node, Metastasis Classification for Lung Cancer: Validation Analysis Based on a Large-Scale Nationwide Database (2013) (65)
Management of the bronchial stump in pulmonary resections: a review of 533 consecutive recent bronchial closures. (2000) (62)
Sublobar resection for early-stage lung cancer. (2014) (62)
DEK oncoprotein regulates transcriptional modifiers and sustains tumor initiation activity in high-grade neuroendocrine carcinoma of the lung (2010) (61)
A non-randomized confirmatory trial of segmentectomy for clinical T1N0 lung cancer with dominant ground glass opacity based on thin-section computed tomography (JCOG1211) (2017) (60)
Supplementary Prognostic Variables for Pleural Mesothelioma (2014) (60)
HER2 gene mutations in non-small cell lung carcinomas: concurrence with Her2 gene amplification and Her2 protein expression and phosphorylation. (2015) (59)
Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors (2004) (58)
Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors. (2008) (58)
The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor (R) Descriptors for Non-Small Cell Lung Cancer. (2019) (58)
Minute pulmonary meningothelial-like nodules: clinicopathologic analysis of 121 patients. (2009) (57)
Mouse Model for ROS1-Rearranged Lung Cancer (2013) (57)
Is Thymomectomy Alone Appropriate for Stage I (T1N0M0) Thymoma? Results of a Propensity-Score Analysis. (2016) (57)
Array‐based comparative genomic hybridization analysis of high‐grade neuroendocrine tumors of the lung (2005) (56)
Comprehensive Immune Profiling of Lung Adenocarcinomas Reveals Four Immunosubtypes with Plasma Cell Subtype a Negative Indicator (2016) (56)
Bright-Field Dual-Color Chromogenic In Situ Hybridization for Diagnosing Echinoderm Microtubule-Associated Protein-Like 4-Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinomas (2011) (56)
Intrapulmonary Lymph Nodes: Thin-Section CT Features of 19 Nodules (2002) (55)
T2 tumors larger than five centimeters in diameter can be upgraded to T3 in non-small cell lung cancer. (2001) (55)
High-grade Lung Adenocarcinoma With Fetal Lung–like Morphology: Clinicopathologic, Immunohistochemical, and Molecular Analyses of 17 Cases (2013) (54)
Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma. (2017) (54)
The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International Participation (2016) (53)
Lymph node dissection for lung cancer: significance, strategy, and technique. (2009) (53)
The usefulness of mutation-specific antibodies in detecting epidermal growth factor receptor mutations and in predicting response to tyrosine kinase inhibitor therapy in lung adenocarcinoma. (2011) (52)
Surgical resection of pulmonary metastases from gastric cancer (1998) (52)
Surgical Outcome of Stage IIIA- cN2/pN2 Non–Small-Cell Lung Cancer Patients in Japanese Lung Cancer Registry Study in 2004 (2012) (48)
Expression of Squamous Cell Carcinoma Markers and Adenocarcinoma Markers in Primary Pulmonary Neuroendocrine Carcinomas (2013) (47)
Gender difference in survival of resected non-small cell lung cancer: histology-related phenomenon? (2009) (46)
Intrapulmonary metastasis of non-small cell lung cancer: a prognostic assessment. (2001) (46)
Surgical Intervention for Non–Small-Cell Lung Cancer Patients with Pleural Carcinomatosis: Results From the Japanese Lung Cancer Registry in 2004 (2015) (46)
Development and validation of diagnostic prediction model for solitary pulmonary nodules (2007) (45)
Clinicopathologic and DNA Cytometric Analysis of Carcinoid Tumors of the Thymus (2001) (45)
Computed tomography-guided coil injection and thoracoscopic pulmonary resection under roentgenographic fluoroscopy. (1994) (45)
Aberrant anaplastic lymphoma kinase expression in high-grade pulmonary neuroendocrine carcinoma (2013) (43)
The new strategy of selective nodal dissection for lung cancer based on segment-specific patterns of nodal spread. (2005) (43)
Management of primary malignant germ cell tumor of the mediastinum. (2004) (43)
Frequent BRAF or EGFR Mutations in Ciliated Muconodular Papillary Tumors of the Lung (2016) (40)
A nonrandomized confirmatory phase III study of sublobar surgical resection for peripheral ground glass opacity dominant lung cancer defined with thoracic thin-section computed tomography (JCOG0804/WJOG4507L). (2017) (40)
Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer. (2005) (39)
Scientific Advances in Thoracic Oncology 2016. (2017) (39)
Tumour size determines both recurrence-free survival and disease-specific survival after surgical treatment for thymoma. (2019) (39)
Value of the Glasgow Prognostic Score as a Prognostic Factor in Resectable Non–Small Cell Lung Cancer (2016) (39)
Nuclear DNA content by cytofluorometry of stage I adenocarcinoma of the lung in relation to postoperative recurrence. (1989) (38)
Clinical impacts of EGFR mutation status: analysis of 5,780 surgically resected lung cancer cases. (2020) (38)
Superior and basal segment lung cancers in the lower lobe have different lymph node metastatic pathways and prognosis. (2008) (38)
Malignant glomus tumor of the lung (2003) (38)
Surgical Management of Recurrent Thymic Epithelial Tumors: A Retrospective Analysis Based on the Japanese Nationwide Database (2015) (37)
A randomized Phase III trial of lobe-specific vs. systematic nodal dissection for clinical Stage I-II non-small cell lung cancer (JCOG1413). (2018) (37)
Clinical statement on the role of the surgeon and surgical issues relating to computed tomography screening programs for lung cancer. (2013) (37)
The IASLC Lung Cancer Staging Project: A Renewed Call to Participation. (2018) (37)
Gene expression profiling of epidermal growth factor receptor/KRAS pathway activation in lung adenocarcinoma (2007) (37)
Clinicopathologic features of resected subcentimeter lung cancer. (2015) (37)
Prognostic significance of hypoxic PET using (18)F-FAZA and (62)Cu-ATSM in non-small-cell lung cancer. (2016) (36)
Radiologic–Pathologic Correlation of Solid Portions on Thin‐section CT Images in Lung Adenocarcinoma: A Multicenter Study (2017) (36)
How should the TNM staging system for lung cancer be revised? A simulation based on the Japanese Lung Cancer Registry populations. (2006) (35)
Thoracoscopy for staging of lung cancer. (1993) (35)
Does the mode of surgical resection affect the prognosis/recurrence in patients with thymoma? (2014) (34)
Prognostic implication of metastasis limited to segmental (level 13) and/or subsegmental (level 14) lymph nodes in patients with surgically resected nonsmall cell lung carcinoma and pathologic N1 lymph node status (2012) (34)
Distinct outcome of stage I lung adenocarcinoma with ACTN4 cell motility gene amplification. (2013) (34)
Clinical and pathological characteristics of EGFR mutation in operable early-stage lung adenocarcinoma. (2017) (34)
Interobserver Agreement in the Nuclear Grading of Primary Pulmonary Adenocarcinoma (2013) (34)
Improvements in Surgical Results for Lung Cancer from 1989 to 1999 in Japan (2009) (33)
The 8th TNM edition for lung cancer: a critical analysis. (2018) (33)
Thoracoscopic evaluation of histologically/cytologically proven or suspected lung cancer: a VATS exploration. (1997) (33)
Global Consultation on Cancer Staging: promoting consistent understanding and use (2019) (33)
Diagnostic and prognostic significance of the alternatively spliced ACTN4 variant in high-grade neuroendocrine pulmonary tumours. (2012) (31)
Modern surgical results of lung cancer involving neighboring structures: a retrospective analysis of 531 pT3 cases in a Japanese Lung Cancer Registry Study. (2012) (31)
Infiltration of tumor‐associated macrophages is involved in tumor programmed death‐ligand 1 expression in early lung adenocarcinoma (2019) (30)
Clinicopathological, Immunohistochemical, and Genetic Features of Primary Lung Adenocarcinoma Occurring in the Setting of Usual Interstitial Pneumonia Pattern (2016) (30)
Refining Prognosis in Lung Cancer: A Report on the Quality and Relevance of Clinical Prognostic Tools (2015) (30)
Clinicopathological characteristics and surgical results of lung cancer patients aged up to 50 years: the Japanese Lung Cancer Registry Study 2004. (2014) (28)
Predictors of non-neoplastic lesions in lung tumours showing ground-glass opacity on thin-section computed tomography based on a multi-institutional prospective study†. (2014) (28)
Left pneumonectomy for lung cancer after correction of contralateral partial anomalous pulmonary venous return. (2005) (28)
Degree of malignancy of thymic epithelial tumors in terms of nuclear DNA content and nuclear area. An analysis of 39 cases. (1988) (27)
Direct derivation of human alveolospheres for SARS-CoV-2 infection modeling and drug screening (2021) (27)
Differences in the prognosis of resected lung adenocarcinoma according to the histological subtype: a retrospective analysis of Japanese lung cancer registry data. (2014) (27)
Histologic prognostic factors for small-sized squamous cell carcinomas of the peripheral lung. (2006) (26)
Minimally invasive approach to early, peripheral adenocarcinoma with ground-glass opacity appearance. (2008) (26)
The International Association for the Study of Lung Cancer Thymic Tumors Staging Project: The Impact of the Eighth Edition of the Union for International Cancer Control and American Joint Committee on Cancer TNM Stage Classification of Thymic Tumors (2020) (26)
CT-guided bronchoscopic barium marking for resection of a fluoroscopically invisible peripheral pulmonary lesion. (1997) (26)
DNA cytofluorometric and nuclear morphometric analyses of lung adenocarcinoma (1989) (25)
Clinicopathologic features and computed tomographic findings of 52 surgically resected adenosquamous carcinomas of the lung. (2014) (25)
Anatomical resections are superior to wedge resections for overall survival in patients with Stage 1 typical carcinoids† (2018) (25)
AFP-producing squamous cell carcinoma of the lung in an adolescent. (1996) (24)
Predicting the prognosis of lung cancer: the evolution of tumor, node and metastasis in the molecular age-challenges and opportunities. (2015) (24)
Mechanical vascular division in lung resection. (2002) (24)
Large-cell neuroendocrine carcinoma of the lung: surgical management. (2014) (24)
Multiple primary cancers or multiple metastases, that is the question. (2010) (24)
Thymoma needs a new staging system. (2004) (24)
Immunohistochemical expression of TTF‐1 in various cytological subtypes of primary lung adenocarcinoma, with special reference to intratumoral heterogeneity (2007) (24)
Solitary mast cell tumor of the lung (1988) (23)
Clinicopathologic Analysis of Multiple (Five or More) Atypical Adenomatous Hyperplasias (AAHs) of the Lung: Evidence for the AAH-Adenocarcinoma Sequence (2010) (23)
Successful Pulmonary Resection of Lung Cancer in a Patient with Partial Anomalous Pulmonary Venous Connection: Report of a Case (2002) (23)
The novel one-step nucleic acid amplification (OSNA) assay for the diagnosis of lymph node metastasis in patients with non-small cell lung cancer (NSCLC): Results of a multicenter prospective study. (2016) (23)
Comparison of Different Clones (WT49 Versus 6F-H2) of WT-1 Antibodies for Immunohistochemical Diagnosis of Malignant Pleural Mesothelioma (2009) (23)
Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA lung adenocarcinoma: comparison of survival outcomes in two clinical trials with propensity score analysis (JCOG1313-A). (2016) (22)
Surgically resected solitary cavitary lung adenocarcinoma: association between clinical, pathologic, and radiologic findings and prognosis. (2015) (22)
Insulin-like growth factor-1 receptor protein expression and gene copy number alterations in non-small cell lung carcinomas. (2013) (21)
Diagnostic accuracy of CT-guided percutaneous cutting needle biopsy for thymic tumours. (2006) (21)
Low-dose CT lung cancer screening in never-smokers and smokers: results of an eight-year observational study (2020) (21)
Lung carcinoma with polypoid growth in the main pulmonary artery: report of two cases. (2000) (21)
Recent improvement of survival prognosis after pulmonary metastasectomy and advanced chemotherapy for patients with colorectal cancer (2017) (21)
Molecular markers and changes of computed tomography appearance in lung adenocarcinoma with ground-glass opacity. (2007) (21)
Early complications. Cardiac complications. (1999) (21)
Role of limited sublobar resection for early-stage lung cancer: steady progress. (2014) (21)
Surgical and nonsurgical approaches to small-size nonsmall cell lung cancer (2014) (21)
Video-assisted lobectomy in the elderly. (1997) (21)
Computed Tomographic Findings and Prognosis in Thymic Epithelial Tumor Patients (2008) (21)
Clinical evaluation of the utility of a flexible 19-gauge EBUS-TBNA needle. (2018) (20)
Prognostic impact of pleural invasion in 1488 patients with surgically resected non-small cell lung carcinoma. (2013) (20)
Surgical treatment of pulmonary metastasis from hepatocellular carcinoma. (2007) (20)
Eighth Edition Staging of Thoracic Malignancies: Implications for the Reporting Pathologist. (2018) (20)
Cytokeratin 19 expression in primary thoracic tumors and lymph node metastases. (2014) (19)
Thoracoscopic surgery versus open surgery for lung metastases of colorectal cancer: a multi-institutional retrospective analysis using propensity score adjustment† (2015) (19)
The Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group: past activities, current status and future direction. (2017) (19)
Hemangioma of the rib: a case report. (2000) (18)
Prognostic value of intraoperative pleural lavage cytology for non-small cell lung cancer: the influence of positive pleural lavage cytology results on T classification. (2014) (18)
Whole-exome and RNA sequencing of pulmonary carcinoid reveals chromosomal rearrangements associated with recurrence. (2020) (18)
Histological Evaluation of the Effect of Smoking on Peripheral Small Adenocarcinomas of the Lung (2008) (18)
Proteomic study of malignant pleural mesothelioma by laser microdissection and two-dimensional difference gel electrophoresis identified cathepsin D as a novel candidate for a differential diagnosis biomarker. (2012) (17)
[Lung cancer in Japan: analysis of lung cancer registry cases resected in 2004]. (2010) (17)
Characteristics of loss of heterozygosity in large cell neuroendocrine carcinomas of the lung and small cell lung carcinomas (2006) (17)
A Phase III trial comparing irinotecan and cisplatin with etoposide and cisplatin in adjuvant chemotherapy for completely resected pulmonary high-grade neuroendocrine carcinoma (JCOG1205/1206). (2014) (17)
Histopathologic prognostic factors in resected adenocarcinomas: is nuclear DNA content prognostic? (1999) (17)
Long-term prognosis of patients with resected adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung. (2021) (17)
Results of T4 Surgical Cases in the Japanese Lung Cancer Registry Study: Should Mediastinal Fat Tissue Invasion Really be Included in the T4 Category? (2013) (16)
Comment on the Proposals for the Revision of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. (2016) (16)
Successful Resection of Hepatocellular Carcinoma with Bronchobiliary Fistula Caused by Repeated Transcatheter Arterial Embolizations: Report of a Case (2007) (16)
Steroid receptor expression in thymomas and thymic carcinomas (2011) (16)
Thymoma displaying endobronchial polypoid growth. (1988) (16)
Randomized Phase III Study of Irinotecan Plus Cisplatin Versus Etoposide Plus Cisplatin for Completely Resected High-Grade Neuroendocrine Carcinoma of the Lung: JCOG1205/1206. (2020) (16)
Sublobar resections for small-sized stage Ia lung adenocarcinoma: a Sino-Japanese multicenter study. (2018) (16)
A VATS lobectomy for lung cancer in a patient with an anomalous pulmonary vein: Report of a case (1997) (16)
A randomised phase II trial of preoperative chemotherapy of cisplatin–docetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG 0204) (2008) (16)
Prognostic factors for malignant pericardial effusion treated by pericardial drainage in solid-malignancy patients (2007) (15)
Early Stage Lung Cancer: Progress in the Last 40 Years (2014) (15)
Mucin-Producing Adenocarcinoma of the Lung: Thin-Section Computed Tomography Findings in 48 Patients and Their Effect on Prognosis (2005) (15)
Minimally invasive open surgery approach for the surgical resection of thoracic malignancies. (2008) (14)
The Japan Lung Cancer Society–Japanese Society for Radiation Oncology consensus-based computed tomographic atlas for defining regional lymph node stations in radiotherapy for lung cancer (2017) (14)
Actinin-4 protein overexpression as a predictive biomarker in adjuvant chemotherapy for resected lung adenocarcinoma. (2017) (14)
Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas. (2012) (13)
Solitary pulmonary granuloma caused by Mycobacterium avium-intracellulare complex. (2007) (13)
Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy ( Proceedings of the National Academy of Sciences of the United States of America (2008) 105, 36, (13568-13573) DOI: 10.1073/pnas.0806268105) (2009) (13)
Thoracoscopic procedures for intrathoracic diseases: The present status (1999) (13)
Clinicopathological analysis of primary lung carcinoma with heterotopic ossification. (2009) (13)
Primary Mediastinal Large B-Cell Lymphoma: A Single-Institution Clinical Study in Japan (2004) (13)
Staging, Tumor Profile, and Prognostic Groups in Lung Cancer or the New Tower of Babel. (2016) (12)
Mucinous micropapillary pattern in lung adenocarcinomas: a unique histology with genetic correlates (2016) (12)
Esophageal and pulmonary metastases from ovarian carcinoma: a case report of long-term survival following metastatic resections. (1991) (12)
Management of bronchial carcinoids: international practice survey among the European Society of Thoracic Surgeons. (2016) (12)
Multiple lung adenocarcinomas showing ground-glass opacities on thoracic computed tomography. (2006) (11)
The Impact of Residual Tumor Morphology on Prognosis, Recurrence, and Fistula Formation after Lung Cancer Resection (2008) (11)
Evaluation of radiologic diagnosis in peripheral clinical IA lung cancers-A prospective study for radiological diagnosis of peripheral early lung cancer (JCOG 0201). (2006) (11)
Cathepsin D as a potential prognostic marker for lung adenocarcinoma. (2012) (11)
Wedge Resection Versus Anatomic Resection: Extent of Surgical Resection for Stage I and II Lung Cancer. (2017) (10)
Distant failure after treatment of postoperative locoregional recurrence of non-small cell lung cancer. (2003) (10)
Closure of fenestra in Clagett procedure: use of rectus abdominis musculocutaneous flap. (1992) (10)
Factors possibly affecting the degree of malignancy in adenocarcinoma of the lung. DNA content and bromodeoxyuridine (BrdU) labeling index. (1989) (10)
Clinicopathological Characteristics of Screen-Detected Lung Cancers (2009) (10)
Consensus report IASLC workshop Bruges, September 2002: pretreatment minimal staging for non-small cell lung cancer. (2003) (10)
A phase III study of adjuvant chemotherapy in patients with completely resected, node-negative non–small cell lung cancer (JCOG 0707) (2020) (9)
Carcinoma of Donor Origin After Allogeneic Peripheral Blood Stem Cell Transplantation (2012) (9)
The IASLC Thymic Tumors Staging Project. The Impact of the 8th Edition of the UICC/AJCC TNM Stage Classification of Thymic Tumors: Results of a Survey. (2019) (9)
Primary lung adenocarcinoma with morule-like components: a unique histologic hallmark of aggressive behavior and EGFR mutation. (2014) (9)
Spontaneous Regression of Metastatic Extraskeletal Myxoid Chondrosarcoma. (2015) (8)
Pleural recurrence after transthoracic needle lung biopsy in stage I lung cancer: a systematic review and individual patient-level meta-analysis (2021) (8)
Impact of the preoperative body mass index on the postoperative outcomes in patients with completely resected non-small cell lung cancer: A retrospective analysis of 16,503 cases in a Japanese Lung Cancer Registry Study. (2020) (8)
A Novel Laser Fiberscope for Simultaneous Imaging and Phototherapy of Peripheral Lung Cancer. (2019) (8)
Combined gastric pull-up and microvascular jejunal transfer procedure after pharyngolaryngoesophagectomy. (1989) (8)
Analysis of Lung Cancer Registry Cases Resected in 2004 Japanese Joint Committee for Lung Cancer Registration (2011) (8)
A Japanese lung cancer registry study at 2002: Japanese joint committee for lung cancer registration (2009) (8)
Prognosis of lung cancer patients with high preoperative carcinoembryonic antigen (CEA) level: Are they surgical candidates. (2004) (7)
Clinical features and outcomes of patients with stage I multiple primary lung cancers (2020) (7)
Cytological features of signet‐ring cell carcinoma of the lung: Comparison with the goblet‐cell‐type adenocarcinoma of the lung (2009) (7)
Malignant pulmonary epithelioid hemangioendothelioma with hilar lymph node metastasis. (2011) (7)
Knowledge of pulmonary neuroendocrine tumors: where are we now? (2014) (7)
Malignant germ cell tumor of the mediastinum: A multimodality therapeutic approach (1994) (6)
Prognostic impact of cancer-associated active fibroblasts and invasive architectural patterns on early-stage lung adenocarcinoma. (2020) (6)
Clinicopathologic aspects of neuroendocrine tumors of the lung (2006) (6)
DNA hypermethylation of the ZNF132 gene participates in the clinicopathological aggressiveness of ‘pan-negative’-type lung adenocarcinomas (2020) (6)
Treatment of choice for stage I non-small cell lung cancer: surgery or radiotherapy? (2006) (6)
PL 02.06 The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for R Status Descriptors for Non-Small Cell Lung Cancer (2017) (5)
[Bronchopleural fistulas developing after pulmonary resections for lung cancer predisposing factors, management, and prognosis]. (1991) (5)
Segmentectomy Versus Lobectomy in Small-Sized Peripheral Non-Small Cell Lung Cancer (JCOG0802/WJOG4607L): A Multicentre, Randomised, Controlled, Phase 3 Trial (2021) (5)
Clinical application of costal coaptation pins made of hydroxyapatite and poly-L-lactide composite for posterolateral thoracotomy. (2008) (5)
Inhibition of vascular adhesion protein‐1 enhances the anti‐tumor effects of immune checkpoint inhibitors (2021) (5)
Response: a critique of the international association for the study of lung cancer lymph node map. (2012) (5)
Solitary fibrous tumor of the pleura: morphogenesis and progression. A report of 36 cases (2016) (5)
Lymph node dissection for lung cancer (2011) (5)
The International Association for the Study of Lung Cancer (IASLC) Molecular Database Project: Objectives, Challenges and Opportunities. (2021) (5)
T 2 tumors larger than five centimeters in diameter can be upgraded to T 3 in non – small cell lung cancer (5)
Node Doubt: Rigorous Surgical Nodal Procurement Combined With Thorough Pathologic Evaluation Improves Non-Small Cell Lung Carcinoma Staging Accuracy. (2016) (5)
Clinicopathological and prognostic features of operable non‐small cell lung cancer patients with diabetes mellitus (2020) (5)
Evaluation of Novel Imaging Devices for Nanoparticle-Mediated Fluorescence-Guided Lung Tumor Therapy. (2019) (4)
[A Japanese lung cancer registry study at 2002]. (2010) (4)
Intratumoral distribution of EGFR-amplified and EGFR-mutated cells in pulmonary adenocarcinoma. (2014) (4)
Debulking surgery for malignant tumors: the current status, evidence and future perspectives. (2021) (4)
Can image analysis on high-resolution computed tomography predict non-invasive growth in adenocarcinoma of the lung? (2015) (4)
Management of ground-glass opacity lesions (2012) (3)
Wedge Resection Versus Anatomic Resection: Extent of Surgical Resection for Stage I and II Lung Cancer. (2017) (3)
Biomarker expression and druggable gene alterations for development of an appropriate therapeutic protocol for pulmonary adenosquamous carcinoma (2015) (3)
Safety and compliance data of the phase III study of adjuvant chemotherapy for patients (pts) with completely resected, pathological (p-) stage I (T1 > 2 cm) non-small cell lung cancer (NSCLC): A Japan Clinical Oncology Group Trial, JCOG0707. (2016) (3)
Commemorating the Silver Anniversary of the International Association for the Study of Lung Cancer International Workshop on Intrathoracic Staging. (2021) (3)
Upregulation of FGF9 in Lung Adenocarcinoma Transdifferentiation to Small Cell Lung Cancer (2021) (3)
Clinical predictors of minimally invasive peripheral adenocarcinoma of the lung: Possible indications for limited surgical resection (2000) (3)
Pulmonary metastasectomy for pulmonary metastasis of breast cancer has a limited prognostic impact: a multi-institutional retrospective analysis (2020) (3)
[The process of the revision of staging system for lung cancer(UICC-7)]. (2009) (3)
Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas. (2012) (3)
Clinical features and prognostic impact of coexisting autoimmune disease other than myasthenia gravis in resected thymomas: analysis of a Japanese multi-institutional retrospective database. (2020) (3)
Subsequent Pulmonary Resection in Patients after Pneumonectomy (2003) (3)
Identity, similarity, and difference between large cell neuroendocrine carcinoma and small cell carcinoma. (2011) (3)
Limited resection for stage IA radiologically invasive lung cancer: a real-world nationwide database study. (2022) (3)
Randomized phase III study of irinotecan/cisplatin (IP) versus etoposide/cisplatin (EP) for completely resected high-grade neuroendocrine carcinoma (HGNEC) of the lung: JCOG1205/1206. (2020) (3)
Pulmonary neuroendocrine tumors with nuclear inclusion. (2013) (3)
OA12.03 Percutaneous Cryoablation for Lung Cancer Patients for Whom Surgery or Radiotherapy is Contraindicated Due to Idiopathic Pulmonary Fibrosis (2017) (3)
A randomized phase II trial of pre-operative docetaxel and cisplatin (DP) or docetaxel alone (D) in clinical (c-) stage IB/II non-small cell lung cancer (NSCLC): Initial report of Japan Clinical Oncology Group trial (JCOG 0204) (2005) (2)
Assessing the quality of lung cancer care in community cancer center hospitals in Japan. (2011) (2)
A case of hepatocellular carcinoma with tumor thrombi in the epiploic vein. (1988) (2)
Cardiac tamponade due to primary malignant pericardial mesothelioma diagnosed with surgical pericardial resection. (2021) (2)
VATS lobectomy for lung cancer (1999) (2)
Cryobiopsy as a reliable technique for the preoperative identification of micropapillary/solid components in early-stage lung adenocarcinoma. (2021) (2)
Training program of general thoracic surgery in Japan: Present status and future tasks. (2020) (2)
Surgery after induction chemotherapy or chemoradiotherapy for locally advanced lung cancer: a technical challenge. (2011) (2)
Seven-year follow-up of preoperative chemoradiotherapy in superior sulcus tumor: Report of a Japan Clinical Oncology Group Trial (JCOG9806). (2010) (2)
The IASLC Thymic Epithelial Tumors Staging Project: unresolved issues to be addressed for the next 9th edition of the TNM classification of malignant tumors. (2022) (2)
[Surgical treatment for metastatic lung tumors]. (1998) (2)
Non-small cell lung cancer, early stage (2012) (2)
Correction: Ultra-High-Resolution Computed Tomography of the Lung: Image Quality of a Prototype Scanner (2015) (2)
Lobe-specific intercostal incisional strategy in video-assisted lobectomy (1998) (2)
Safety and efficacy of salvage surgery for non-small cell lung cancer: a retrospective study of 46 patients from four Keio-affiliated hospitals (2022) (2)
A Case of Lipofibroadenoma of the Thymus (2018) (2)
A case of pulmonary epithelioid hemangioendothelioma. (2010) (2)
Robotic surgery. (2018) (1)
Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA pulmonary adenocarcinoma: Comparison of prospective clinical trials with propensity score analysis (JCOG1313-A). (2014) (1)
Lobe-specific intercostal strategy in video-assisted lobectomy. (1998) (1)
Ectopic Adrenocorticotropic Hormone-Secreting Bronchial Carcinoid Diagnosed by Balloon-Occluded Pulmonary Arterial Sampling. (2016) (1)
Two cases of idiopathic intrapulmonary hematoma difficult to differentially diagnose from lung tumor based on images (2015) (1)
[Revision of TNM Classification for Lung Cancer by Staging and Prognostic Factors Committee of LASLC (International Association for the Study of Lung Cancer)]. (2016) (1)
The IASLC Lung Cancer Staging Project: Methods and Guiding Principles for the Development of the 9th Edition TNM Classification. (2022) (1)
Feasibility and safety of percutaneous cryoablation under local anesthesia for the treatment of malignant lung tumors: a retrospective cohort study (2022) (1)
Should Mediastinal Fat Tissue Invasion Really be Included in the T 4 Category ? (2013) (1)
The IASLC Lung Cancer Staging Project: Overview of Challenges and Opportunities in Revising the Nodal Classification of Lung Cancer. (2022) (1)
A case of primary small cell carcinoma in the trachea of a young man (2005) (1)
Detection of lung cancer by helical CT scan: a new method of mass screening. (1999) (1)
[The degree of malignancy in lung adenocarcinoma and related factors-- nuclear DNA content and bromodeoxyuridine labeling index]. (1989) (1)
Lobe-specific nodal dissection for clinical stage I-II non-small cell lung cancer: Japanese multi-institutional retrospective study using a propensity score analysis. (2016) (1)
A consensus-based computed tomographic atlas for defining the regional lymph node stations in radiotherapy for lung cancer: The JLCS - JASTRO joint committee for developing an atlas of the regional lymph node stations in radiotherapy treatment planning for lung cancer (2015) (1)
In response to the review article in Surgery Today: JCOG trials for small adenocarcinomas of the lung (2014) (1)
Clinicopathological characteristics of screen-detected lung cancers (Journal of Thoracic Oncology (2009) 4, (615-619)) (2009) (1)
A Case of Pulmonary Epithelioid Hemangioendothelioma-Review of the Literature-. (2003) (1)
[Practice guidelines for lung cancer invading the neighboring anatomic structures]. (2004) (1)
Four cases of completion lobectomy for locally relapsed lung cancer after segmentectomy (2020) (1)
Histological and prognostic data on surgically resected early-stage lung adenocarcinoma (2020) (1)
[Neuroendocrine tumors of the lung]. (2004) (1)
Lipofibroadenoma arising in hyperplastic thymic tissue: Possible perivascular origin of lipofibroadenoma (2021) (1)
A CASE OF LEIOMYOSARCOMA OF THE GALLBLADDER AND A REVIEW OF THE JAPANESE LITERATURE (1986) (1)
The first transplant from a brain-dead patient in Japan. (1999) (1)
72PD LOBECTOMY IN COMBINATION WITH RADICAL LYMPHADENECTOMY IS THE MOST FREQUENT SURGICAL INTERVENTION PERFORMED IN PATIENTS RANDOMIZED IN MAGRIT TRIAL EVALUATING MAGE-A3 ANTIGEN-SPECIFIC CANCER IMMUNOTHERAPEUTIC (ASCI) AS ADJUVANT TREATMENT IN STAGE IB IIIA NSCLC (2011) (1)
臨床IA期末梢型非小細胞肺癌における放射線学的診断の評価:末梢型早期肺癌の放射線学的診断の前向き研究(JCOG0201) (2006) (1)
Promoter Methylation of the CADM 1 and 4.1 B Genes Occurs Independently of the EGFR or the KRAS 2 Mutation in Non-Small Cell Lung Cancer (2015) (0)
MTE15.01 Identifying High Risk Patients: What Makes a Patient Too High Risk for Surgery and Who Decides? (2018) (0)
MUC6 expression is a preferable prognostic marker for invasive mucinous adenocarcinoma of the lung (2022) (0)
First lung transplant from living donors in Japan. (1999) (0)
29 – Extent of Surgical Resection for Stage I and II Lung Cancer (2018) (0)
The value of 'purging' in bone marrow transplantation: A controversial technique (2000) (0)
OA06.04 Constructing a Global Molecular Database for Thoracic Malignancies: The IASLC Molecular Subcommittee Lung Cancer Dataset (2021) (0)
Two cases of resection of micronodular thymoma with lymphoid stroma (2021) (0)
68PTHE UTILITY OF ACTININ-4 PROTEIN OVEREXPRESSION AS A PREDICTIVE BIOMARKER FOR THERAPEUTIC EFFECT OF ADJUVANT CHEMOTHERAPY TO THE RESECTED LUNG ADENOCARCINOMA (2015) (0)
Reply to J. L. Derks et al. (2021) (0)
Large cell neuroendocrine carcinoma: A poor prognostic entity (2000) (0)
MA 05.04 Distinct Immunosuppressive Microenvironment Determines Poor Prognosis of Nonsmokers with Adenocarcinoma of Non-Small Cell Lung Cancer (2017) (0)
P-099PREDICTION OF LYMPH NODE METASTASIS IN CLINICAL STAGE I ADENOCARCINOMA OF THE LUNG (2017) (0)
PUB055 Nodal Status Based on the Anatomical Location or the Number of Lymph Nodes Metastasis (2017) (0)
P2.04-016 Is FDG-PET Useful for Distinguishing between Thymic Epithelial Tumors and Malignant Lymphoma?: Topic: Thymic Malignancies Clinical and Translational (2017) (0)
Invited commentary. (2015) (0)
P1.05-009 Analysis of Postoperative Prognosis in Terms of the Difference Between the Invasive Growth Area and the Total Tumor Diameter (2017) (0)
Reply to ‘Addressing the challenge of proper delineation of lymph node stations in modern radiotherapy for lung cancer’ (2018) (0)
IBS25.01 Eastern Perspective (2019) (0)
E4. The surgical approach to early peripheral NSCLC (2005) (0)
The Japanese lung cancer registry conducted by the Japanese Joint Committee for Lung Cancer Registration (2012) (0)
Two surgical cases of pneumothorax associated with Ehlers-Danlos syndrome (2022) (0)
P1.14-26 Long Term Outcome and Clinicopathological Features of Thymic Carcinoma - A Retrospective Study of 25 Cases at a Single Institution (2018) (0)
Institutional report - Thoracic general Thymoma needs a new staging system (2004) (0)
[Video-assisted thoracic surgery (VATS) for intrathoracic tumors]. (1994) (0)
IASLC lung cancer staging project: the new database to inform revisions in the ninth edition of the TNM classification of lung cancer. (2023) (0)
Adjuvant chemotherapy in patients with completely resected small cell lung cancer: a retrospective analysis of 26 consecutive cases. (2014) (0)
The process of the revision and brief summary of new staging system for lung cancer (UICC-7) (2010) (0)
A clinicopathologic study of primary mediastinal large B-cell lymphoma (MLBCL) at a single institution in Japan. (2004) (0)
Giant lamellar bodies associated with adenocarcinoma of the lung (2016) (0)
E6. The IASLC staging project: A surgeon's perspective (2005) (0)
Diagnosing Thymic Neoplasia (1989) (0)
Boundary between N1 and N2 stations in lung cancer: back to the future of anatomy: Reply (2001) (0)
Corrigendum to "Prognostic impact of cancer-associated active fibroblasts and invasive architectural patterns on early-stage lung adenocarcinoma" [Lung Cancer 145 (2020) 158-166]. (2020) (0)
EP1.18-16 Surgery for Locally Advanced Lung Cancer Invading the Spine After Chemoradiotherapy (2019) (0)
Remembrance: Keiichi Suemasu, MD, 1926–2015 (2015) (0)
A CASE OF SOLITARY TUBERCULOMA OF THE LIVER AND A REVIEW OF THE JAPANESE LITERATURE (1987) (0)
MA06.06 A Phase III Study of Adjuvant Chemotherapy in Patients with Completely Resected, Node-Negative Non-Small Cell Lung Cancer (2019) (0)
[Controversies of video-assisted thoracic surgery (VATS)]. (2005) (0)
WS05.03 How to Perform a Proper Systematic Nodal Dissection in Lung Cancer Surgery (2019) (0)
ED05.01 What’s New in Lung Cancer Staging? (2017) (0)
Stage IV thymic mucinous adenocarcinoma under long-term disease control after primary tumor resection: A case report (2022) (0)
MA10.04 Long-term Follow-up Study of Thymic Epithelial Tumors. Report of the Updated Nation-wide Database in Japan (2022) (0)
A resected case of localized pleural mesothelioma (2022) (0)
[Operation for preservation of lung function in lung cancer cases--study on bronchoplasty]. (1991) (0)
WT1 peptide-based immunotherapy for refractory thymic epithelial malignancies (2019) (0)
IT-001: APPROPRIATE EXTENT OF RESECTION FOR THYMOMA WITH RESPECT TO RECURRENCE (2012) (0)
Biomarkers in lung cancer: Present status and future perspective -what is a useful biomarker for lung cancer? (2009) (0)
Pulmonary granuloma associated with ulcerative colitis resembling lung cancer diagnosed by surgical resection: A case report (2022) (0)
P1.05-17 Clinicopathological Characteristics of Primary Lung Cancers Associated with Emphysematous Bullae (2018) (0)
PD-127 Prognostic implication of microscopic residual tumor at the bronchial margin in non-small cell lung cancer (2005) (0)
MS 03.02 Limited vs. Standard Surgical Resection: Japanese Experience (2017) (0)
239 Diagnostic utility of GLUT-1 expression in the differential diagnosis between reactive mesothelium and malignant mesothelioma (2006) (0)
13 Lung Carcinoma (1995) (0)
Detection of the early stage of spontaneous hemopneumothorax by CT attenuation values (2020) (0)
P-061 Promoter methylation of the DAL-114.1B predicts poor prognosis in non-small cell lung cancer (2005) (0)
E5. The degree of malignancy of neuroendocrine tumors of the lung: A Japanese registry study (2005) (0)
Direct Reprogramming of Mouse Fibroblasts into Pulmonary Epithelial-Like Cells (2019) (0)
In MemoriamIn Memoriam (2007) (0)
Predictors of pathological early lung adenocarcinoma among clinical ia disease: possible indication for lesser surgical resection: A4-02 (2007) (0)
F-046DOES THE DEGREE OF PLEURAL INVASION INFLUENCE SURVIVAL IN COMPLETELY RESECTED NON-SMALL CELL LUNG CANCER? CHECKING THE VALIDATION OF T DESCRIPTOR IN THE TNM STAGING (2015) (0)
P3.17-10 Outcome of Surgical Resection for Superior Sulcus Tumor: Experience at a Single Institution (2018) (0)
Comments on the proposed new international lymph node international association for the study of lung cancer map (2009) (0)
Estimation of the volume of postoperative intrathoracic bleeding after pulmonary resection: Is the volume of chest tube output predictive of that of intrathoracic hematoma? (2011) (0)
P3.13-031 Predicting Factor for the Dissociation of the Diameter Between Radiographical Solid Part and Pathological Invasive Part in Lung Adenocarcinoma (2017) (0)
[Pulmonary epithelioid hemangioendothelioma]. (2013) (0)
WS04.05 Developing the IASLC Lung Cancer Staging Database and Recommendations for the 9th Edition (2019) (0)
P26.07 Video-Assisted Thoracoscopic Surgery for Stage I Thymoma: Short-Term Outcomes and Appropriate Indications (2021) (0)
P1.05-005 Percutaneous Cryoablation for Lung Cancer Patients with Idiopathic Pulmonary Fibrosis (2017) (0)
P1.17-017 Usefulness of FDG-PET for Differentiating Thymic Epithelial Tumors from Malignant Lymphomas (2017) (0)
Lung cancer and cholecystitis due to gallbladder metastasis treated with lobectomy and cholecystectomy; case report and review (1991) (0)
Five-year follow-up of preoperative chemotherapy (Cx) of docetaxel with or without cisplatin for clinical (c-) stage IB/II non-small cell lung cancer (NSCLC): Report of a Japan Clinical Oncology Group study (JCOG0204). (2010) (0)
EP07.03-007 Clinicopathological Analyses for Predicting Recurrence After Complete Resection of Thymoma (2022) (0)
PD-050 A phase II trial of pre-operative chemoradiotherapy followedby surgical resection in Pancoast tumors: Report of a Japan Clinical Oncology Group trial (JCOG 9806) (2005) (0)
[Standard surgical procedures in lung cancer]. (2002) (0)
Mulitpoint oncology teleconference, Japan. (2004) (0)
Long-term survival after multidisciplinary treatment for large-size secondary osteosarcoma of the rib: A case report (2023) (0)
Current Approaches to Surgical Management of Lung Cancer (2014) (0)
Inside the USCAP Journals (2022) (0)
Abstract 2375: Prognostic significance of the alternatively splicedACTN4variant in high-grade neuroendocrine pulmonary tumors. (2013) (0)
Trimodality therapy in superior sulcus tumor (2012) (0)
Title Ultra-High-Resolution Computed Tomography of the Lung : Image Qualityof a Prototype Scanner (2019) (0)
Abstract 5892: Whole-exome and RNA sequencing reveals chromosomal rearrangements associated with the recurrence of pulmonary carcinoid (2020) (0)
Major lung resection by VATS (1997) (0)
[Operative vascular techniques in lung resections for cancer]. (2006) (0)
MA04.05 T3 Defining Features Influence Long Term Survival after Resection of T3N0M0 NSCLC (2022) (0)
O-043 A randomized phase II trial of pre-operative docetaxel and cisplatin (DP) or docetaxel alone (D) in clinical (c-) stage IB/II nonsmall cell lung cancer (NSCLC): Initial report of Japan Clinical Oncology Group trial (JCOG 0204) (2005) (0)
Abstract 4036: Prognostic value of infiltrating immune cell profiling in lung adenocarcinoma (2016) (0)
Quality indicators and the Japanese lung cancer registry (2012) (0)
P1.16-37 Clinicopathological Characteristics and Prognostic Factors of Operable Non-Small Cell Lung Cancer Patients with the Diabetes Mellitus (2018) (0)
FP01.04 Prospective Observational Study of Activities of Daily Livings in Elderly Patients After Lung Cancer Surgery (JCOG1710A) (2021) (0)
P1.05-051 Safety and Compliance Data of the Phase III Study of Adjuvant Chemotherapy in Completely Resected P-Stage I Non-Small Cell Lung Cancer: JCOG0707: Topic: Neoadjuvant and Adjuvant Chemotherapy (2017) (0)
Limited resection for early-stage thymoma: minimally invasive resection does not mean limited resection. (2021) (0)
Two Cases of Perforation of the Sigmoid Colon Due to Colonoscopy (1986) (0)
Hazard Function Analysis of Recurrence in Patients with Curatively Resected Lung Cancer: Results from the Japanese Lung Cancer Registry in 2010 (2022) (0)
Invited commentary. (2015) (0)
A Phase III Study of Adjuvant Chemotherapy in Patients with Completely Resected, Node-Negative Non-Small Cell Lung Cancer (2020) (0)
Double stapling method for closure of intraoperative alveolar air leakage adjacent to the staple line: a randomized experimental study on ex vivo porcine lungs (2021) (0)
Intrapulmonary metastasis (new T4) of non-small cell lung cancer. A prognostic assessment (2000) (0)
[State of the art treatment of lung cancer: non-small cell lung cancer--surgical treatment]. (1997) (0)
P3.01-006 Prognostic Impact of Tumor Spread through Air Spaces in Limited Resection for pStage I Lung Cancer (2017) (0)
P3.16-05 A Nanotechnology-Enabled Strategy for Image-Guided Transbronchial and Transpleural Photothermal Therapy of Peripheral Lung Cancer (2018) (0)
P1.11-10 Serum MicroRNA Biomarkers for Screening of Resectable Lung Cancer (2019) (0)
New research subjects in Grant-in-Aid for Cancer Research 1999-2000 from the Ministry of Health and Welfare, Japan. (1999) (0)
A case of inflammatory myofibroblastic tumor of the lung which caused hemothorax and hemoptysis metachronously (2004) (0)
Successful management of traumatic flail chest by the Nuss procedure: A case report (2021) (0)
Separate evaluation of unilateral lung function using upright/supine CT in a patient with diaphragmatic paralysis (2022) (0)
Abstract 4679: Novel pathway mutations in malignant mesothelioma revealed by high-throughput DNA and RNA sequencing (2014) (0)
A Case of Solitary Pulmonary Metastasis from Thymoma Resected 19 Years After Surgery (2020) (0)
[Is lymph node dissection necessary in small, non-small-cell carcinoma of the lung occurring at the peripheral region?]. (1997) (0)
MA23.11 Lobe-Specific Nodal Dissection for Clinical Stage I and II Non-Small Cell Lung Cancer: Japanese Multi-Institutional Retrospective Study (2018) (0)
Anatomic segmental resection (2015) (0)
P3.01-015 Prognostic Impact of Histologic Invasion Factors in Pulmonary Adenocarcinoma, with Particular Focus on the Pattern of Architectural Remodeling: Topic: Morphology (2017) (0)
M01-02: Treatment for the screen-detected lung cancer: characteristics and outcome (2007) (0)
Abstract 2094: Correaltions between genome-wide DNA methylation profiles and genomic driver aberrations during multistage lung adenocaricinogenesis (2021) (0)
The TNM System Is Adequate for Making Treatment Decisions and Prognostication in Lung Cancer. (2022) (0)
Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma. (2023) (0)
Gene Amplification of ACTN4 in Lung Cancer: A Novel Prognostic Indicator for Stage I Adenocarcinoma of The Lung (2012) (0)
Biological and Pathological Characteristics of Thymic Epithelial Tumors (1990) (0)
Carcinoma of the Lung Surgical Management (2014) (0)
[Modern radical resection for lung cancer; a critique on the video-assisted radical resection]. (2006) (0)
A Report from the Japanese Joint Committee of Lung Cancer Registry: a Study of 18,973 Surgical Cases in 2010 -Secondary Publication- (2019) (0)
Can Prognostic Significance of Lymph Node Dissection Be Assessed by Randomized Clinical Trials in Patients with Lung Cancer (1997) (0)
OA10.05 EGFR Gene Mutations Affect Tumor-Infiltrating Stromal Cell Components in Early-Stage Lung Adenocarcinoma (2017) (0)
[Role of Surgery in Multimodality Treatment for Non-small Cell Lung Cancer;Current Status and Future Perspectives]. (2018) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Hisao Asamura?

Hisao Asamura is affiliated with the following schools:

Kitasato University
Keio University
Tokyo Medical University

Hisao Asamura's Academic­Influence.com Rankings

Why Is Hisao Asamura Influential?

Hisao Asamura's Published Works

Published Works

What Schools Are Affiliated With Hisao Asamura?

Hisao Asamura's AcademicInfluence.com Rankings